Artemis II Mission Includes Bone Marrow Experiment with Potential Earth Medicine Applications

The Artemis II mission, NASA's first crewed flight under the Artemis program, involves four astronauts traveling around the Moon. Among the experiments scheduled for the mission is one focused on the crew's bone marrow. The experiment will collect samples from the astronauts to analyze changes caused by microgravity.

This bone marrow study is part of a broader set of scientific investigations during the 10-day mission. The samples will be returned to Earth for detailed examination. Researchers aim to understand how spaceflight impacts human bone marrow function, which produces blood cells.

Donald Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, provided insights into the experiment. Ingber explained that the study could yield data applicable to medical practices on Earth. The Wyss Institute collaborates with NASA on various space-related biomedical research projects.

The Artemis II mission serves as a precursor to future lunar landings, including Artemis III planned for 2026. Bone marrow research in space builds on previous missions like those on the International Space Station. Such studies have previously contributed to advancements in treatments for blood disorders and regenerative medicine.

The experiment's design involves non-invasive collection methods suitable for the mission's duration. Post-mission analysis will occur at specialized facilities on Earth. NASA officials have stated that results could inform astronaut health protocols for longer-duration missions to Mars.

This initiative highlights the dual benefits of space exploration for space travel and terrestrial health. The bone marrow data may assist in developing therapies for conditions affected by aging or disease, similar to microgravity effects. Further details on the experiment's progress will be available after the mission concludes in late 2024.